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Abstract A significant increase in the expression and activity of 
tissue transglutaminase (tTG), one of the effector elements of 
apoptosis, was observed during involution of thymus elicited by 
treatment with either anti-CD3 antibody or dexamethasone or by 
irradiation. The blood plasma concentration of E(y-glutamyl)ly-
sine isodipeptide, the end-product of the digestion of transglu-
taminase cross-linked proteins, was also elevated in each of these 
cases. tTG was localized in cells of the cortical layer of the 
thymus and immunofluorescence double staining revealed that 
the enzyme appeared in the apoptotic cells. None of these 
observations could be made when apoptosis was induced by fas-
receptor stimulation. The lack of tTG activity in /as-stimulated 
cells was accompanied with a less organized apoptotic morphol-
ogy. Our data suggest that distinct signalling pathways, which 
induce apoptosis within the same cell type, can differentially 
regulate the expression of tTG, and this enzyme may be involved 
in structural stabilization of the apoptotic cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The cell-autonomous process of apoptosis was originally 
defined by morphological criteria (cellular shrinkage, mem-
brane blebbing, chromatin condensation and fragmentation) 
established in living tissues [1]. The intense genetic, biochem-
ical and cellular studies of recent years have revealed that 
distinct molecular pathways of apoptosis may exist beyond 
this characteristic morphology in various cells and even in 
one cell type [2,3]. One of the critical issues in the biochemical 
characterization of apoptosis is to dissect these pathways clar-
ifying which of the effector elements (e.g. endonucleases, pro-
teases, transglutaminases) are activated and how they are 
regulated by various death signals [3]. Maturing thymocytes 
are very suitable for such studies because their death program 
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can be initiated via several distinct molecular pathways [2]: 
stimulation of TCR and CD3 induces changes in second-mes-
senger systems [4], glucocorticoids bind to steroid receptors 
[5], while inhibition of topoisomerase II or irradiation causes 
direct DNA damage [6,7]. Each of these pathways appears to 
induce distinct sets of genes. The transcripts RP-2 and RP-8 
are expressed in thymocyes following treatment with gluco-
corticoids [8]. DNA damage leads to pi3 induction [9,10]. The 
immediate-early gene, nur 77 is induced in response to TCR 
signals but not by glucocorticoids or ionizing radiation [11]. 
Fas stimulation, on the other hand, induces apoptosis without 
the involvement of new macromolecular synthesis [12]. 
Characteristic biochemical features of apoptosis have been 
observed in all the four forms of thymocyte death mentioned 
above [5-7,12-14], suggesting that common effector elements 
of apoptosis are activated by distinct molecular signaling 
pathways. The induction and activation of the Ca2+-depend-
ent tTG has also been implicated in the molecular events of 
apoptosis [for references see [15]]. Transglutaminases catalyze 
a protein cross-linking reaction in which gamma-carboxamide 
groups of peptide bound glutamine residues serve as acyl do-
nors and primary amino groups of peptide-bound lysine func-
tion as acceptor substrates [16]; it has been suggested that 
enzymatic cross-linking of proteins by tTG leads to the as-
sembly of a stable protein scaffold in the dying cells [15]. 
However, it is not known which and how apoptotic pathways 
switch on the catalytic action of transglutammase. Data pre-
sented in our paper suggest that induction and activation of 
tTG is part of the biochemical pathway of thymocyte apop-
tosis induced by dexamethasone (DXM), TCR activation and 
DNA damage but not of that initiated by /a.v-receptor stim-
ulation, and the lack of tTG activity is accompanied with a 
less organized apoptotic morphology. 
2. Materials and methods 
2.1. Materials 
Anti-CD3 and anti-fas monoclonal antibody were purchased from 
Pharmingen (San Diego, CA), anti-tTG antibody was a gift of Dr. 
Paul Birckbichler (Oklahoma City, OK). Horseradish peroxidase-la-
belled goat anti-mouse and anti-rabbit IgG, dexamethasone-21 -ace-
tate, N,N'-dimethyl-casein were from Sigma Chemical Co. (St. Louis, 
MO). Luminol and bovine serum albumin were from Reanal (Buda-
pest, Hungary), PVDF membrane was from Millipore Corp. (Bred-
ford, MA) while [3H]putrescine (26 Ci/mmol) was purchased from 
Amersham. All other reagents were of analytical grade and obtained 
from commercial sources. 
2.2. Experimental animals 
Male NMRI, 4-week-old mice with a body weight of 27.1 ± 1.5 g 
purchased from LAT1 (Godollo, Hungary) were used. For the induc-
tion of thymic involution and apoptosis mice were treated i.p. with 0.5 
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mg dexamethasone-21-acetate or 12.5 ug anti-fas or 80 ug anti-CD3 
monoclonal antibody dissolved in 0.2 ml of physiological saline, or 
were exposed to 5 Gy irradiation. 
2.3. Determination of transglutaminase activity 
Thymus was collected from control or treated animals at various 
time points after treatment, washed extensively with PBS and homo-
genized in 0.1 M Tris-HCl, pH 7.5, containing 0.25 M sucrose, 0.5 
mM EDTA, and 1 mM PMSF. tTG activity in homogenates was 
measured by detecting the incorporation of [3H]putrescine into 
N,N'-dimethyl-casein as it was described previously [17]. Enzyme ac-
tivity was calculated as nmoles of [3H]putrescine incorporated into 
casein in 1 h by 1 mg cellular protein. 
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Fig. 1. Changes in the activity of tTG during in vivo apoptosis of 
thymocytes induced via distinct signalling pathways. Changes in thy-
mic weight (A) and tTG activity (B) at various time points after in 
vivo induction of apoptosis by anti-fas antibody (□) dexametha-
sone-21-acetate ( v ) , irradiation (▼) or anti-CD3 antibody (•) as 
compared to treatment with physiological saline alone (o). Data 
represent mean ± SD of three determinations. 
2.4. Western blot analysis 
Thymus was collected from control or treated animals at various 
time points after treatment, washed extensively with PBS and homo-
genized in 0.1 M Tris-HCl, pH 7.5, containing 0.25 M sucrose, 0.5 
mM EDTA, and 1 mM PMSF. Homogenates containing 1 mg/ml 
protein were denaturated in Laemmli buffer [18]. The proteins were 
then separated on 10% SDS-polyacrylamide gels and transferred to 
PVDF membranes (Millipore). Membrane was blocked and probed 
with a monoclonal antibody against tTG, diluted 1:100. tTG was 
detected by using a horseradish peroxidase-labelled second antibody 
and the Amersham ECL system. 
2.5. Immunohistochemistry and co-localization of tTG and apoptotic 
nuclei in thymus sections 
For immunohistochemical staining and immunofluorescence thy-
mus was fixed with freshly prepared formaldehyde and embedded in 
paraffin. Sections (5 urn thick) were cut and picked up on slides then 
dewaxed with xylene, hydrated and finally digested with 10 ug/ml 
proteinase K for 30 min at room temperature to unmask antigenic 
structures. Affinity purified polyclonal rabbit antibody raised against 
human tTG [19] was used to detect enzyme protein. Biotinylated 
donkey anti-rabbit link antibody (Amersham, Buckinghamshire, 
UK) and ABC-AP (Dakopatts, Glostrup, Denmark) was applied to 
develop the colour reaction. Fragmented DNA was labelled with di-
goxigenin-11-dUTP using calf-thymus TdT [20] and later detected by 
TRITC-conjugated sheep-anti-digoxigenin f(ab) fragments (all from 
Boehringer Mannheim, Mannheim, Germany). For immunofluores-
cent staining a FITC-conjugated swine anti-rabbit antibody (Dako-
patts) was applied. Controls were performed by using normal rabbit 
serum instead of primary rabbit antibodies and omission of TdT, 
respectively. Photographs were taken by a Leitz Orthoplan micro-
scope equipped with Ploemopak epi-illuminator and using dual exci-
tation filter. 
2.6. Transmission electron microscopy 
Samples (1 mm3) of the thymus (control or treated with various 
apoptotic stimuli) were collected and routinely processed for trans-
mission electron microscopy (TEM). Random serial photographs 
(1500-60 000 X) were taken without prior knowledge of the actual 
treatment which the animals had prior dissection. 
2.7. Preparation of plasma samples and determination of the 
concentration of e(y-glutaminyl)lysine isodipeptide 
Citrated platelet poor plasma was produced from whole blood anti-
coagulated with 0.109 M trisodium citrate (ratio 9:1) by centrifuga-
tion at 2000 Xg for 10 min. All samples were stored at -20°C and 
thawed at +37°C immediately prior to analysis. Pooled plasma were 
obtained from 3 mice for each time point. To determine the concen-
tration of e(y-glutamyl)lysine isodipeptide several purification and an-
alytical steps were carried out as described [21] except that instead of 
proteolytic digests, protein-free plasma sample prepared by centrifu-
gation at +4°C in a Centrifree partition device (Amicon, cut-off 5000) 
was used as a starting material. The reproducibility of the method is 
reflected in a coefficient of variation of less than 10%. 
3. Results 
3.1. Transglutaminase is induced in thymus after induction of 
apoptosis in vivo via the TCR, GR and P53 signal 
transduction pathways but not via fas-receptor stimulation 
Mice were injected with DXM, anti-fas or anti-CD3 anti-
body or exposed to 5 Gy irradiation to induce apoptosis in 
the thymus. Each treatment resulted in a very similar time 
course of thymic involution (Fig. 1A): irradiation induced 
the highest rate of cell death followed by that elicited by 
anti-/ar, anti-CD3 and DXM treatments. With anti-/os and 
anti-CD3 treatment or following irradiation a significant de-
crease in thymic weight was detected already at 6 h. At 48 h 
following each treatment 80% of the thymus disappeared and 
no further decrease was found in the thymic weight at later 
time points (data not shown). As shown in Fig. IB each treat-
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Fig. 2. Changes in transglutaminase expression studied with Western blot analysis during in vivo apoptosis of thymocytes induced via distinct 
signalling pathways. L: tissue homogenate from mouse liver where tTG is constitutively expressed. tTG indicates the position of the electropho-
retic migration of mouse tTG (77 kDa). 
ment, with the exception of anti-/as, resulted in a significant 
increase in tTG activity from an initial 1.45 ±1.2 with a peak 
activity of 25.3±2.1, 19.3 ± 1.8 and 26.2±3.1 nmol/h/mg pro-
tein following anti-CD3, DXM treatment and irradiation, re-
spectively. The first significant increase in activity (P < 0.05 by 
Student's t test) was observed after 6 h and reached the peak 
value at 24 h in each case. 
Fig. 2 shows changes in the expression of tTG determined 
by Western blot analysis after induction of apoptosis with 
irradiation, anti-CD3 or DXM. As time progressed more 
and more tTG was expressed, reaching maximum amounts 
at 24 h. There was no change in the expression of tTG if 
apoptosis was induced via /as-receptor stimulation. 
3.2. tTG is expressed primarily in the apoptotic cells of the 
cortical layer of the thymus 
Thymus sections at various time points after each treatment 
were stained for tTG protein. The presence of tTG in thymus 
of control animals was limited to the endothelial cells lining 
the vessels (section not shown) where tTG is contitutively ex-
pressed [22]. As the apoptotic process induced by DXM was 
accelerated and the involution of the thymus progressed, more 
and more cells became tTG positive. All these tTG-positive 
cells were localized within the cortical layer of the thymus 
(Fig. 3). The cortical layer of the thymus is known to contain 
the immature CD4+CD8+, bcl-2~ thymocytes which are sen-
sitive to apoptotic stimuli [23]. Similar pictures were found 
with anti-CD3 treatment or after irradiation, while in thymus 
treated with anti-/ay antibody tTG expression was not ob-
served (these sections are not shown). 
To prove that cells expressing tTG were indeed those which 
entered the apoptotic program, thymic cells were immuno-
stained for both tTG and apoptotic nuclei using the TdT 
reaction for the latter. As shown in Fig. 4A most of the cells 
were negative for the presence of both tTG and apoptotic 
nuclei in thymus of control animals, though a very few pos-
itive cells were seen representing those undergoing spontane-
ous apoptosis. At 12 h after DXM treatment (Fig. 4B) the 
Fig. 3. Immunolocalization of tTG in mouse thymus at 24 h after 
the induction of apoptosis by DXM. Thymus sample was collected 
from a DXM-treated animal at 24 h after treatment, and immuno-
stained for tTG as it was described in Section 2. Arrow points out 
to the cortical layer which became strongly tTG positive after apop-
tosis induction. This layer contains the apoptosis-sensitive 
CD4+CD8+ thymocytes (23). (Magnification X 160). 
310 Z Szondy et al.lFEBS Letters 404 (1997) 307-313 
number of tTG-positive cells in the cortical layer was signifi- were negative for DNA fragmentation at this time point; in a 
cantly increased. However, the majority of tTG-positive cells typical experiment the ratio of TdT~tTG+ , TdT+ tTG+ and 
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Fig. 4. Co-localization of tTG and apoptotic nuclei in thymic sections. Thymus was collected at 0 (A), 6 (B) and 24 h (C) after treatment with 
DXM, or 6 h following the injection of anti-fas antibody (D). Thymus sections were stained for both tTG (green) and apoptotic nuclei (red) as 
was described in Section 2. Note that the appearance of tTG expression is prior to that of the apoptotic nuclei (B), tTG is co-localized with 
the apoptotic nuclei (appears as yellow) of DXM-treated thymocytes (C) and lack of tTG expression in the anti-fas-treated thymus though the 
apoptotic nuclei are present in comparable number to that of the DXM-treated one at the same time point (D). (Magnification X 800). 
TdT+tTG" cells were 10:4:0.5, respectively. At 24 h (Fig. 4C) 
the number of tTG-positive cells were further increased and 
tTG positivity was found in apoptotic thymocytes containing 
fragmented DNA; the ratio of TdT"tTG+, TdT+tTG+ and 
TdT+tTG~ cells were 6:5:0.5, respectively. Similar pictures 
were found if the animals were irradiated or treated with 
anti-CD3 antibody (sections not shown). These observations 
suggest that tTG is induced in the pre-apoptotic thymocytes 
and the induction of the expression of the enzyme is prior to 
endonuclease activation. 
As shown on Fig. 4D the number of apoptotic nuclei is also 
increased in the thymus of animals treated with anti-fas anti-
body. However, there was no change in the pattern or inten-
sity of the expression of tTG providing further evidence that 
the enzyme is not induced during apoptosis initiated through 
fas stimulation. 
3.3. Elevated levels of plasma £(y-glutamyl)lysine isodipeptide 
indicate activation of tTG in the dying cells of involuting 
thymus 
Covalent e(Y-glutamyl)lysine crosslinks are formed between 
polypeptide chains of proteins when tTG is active within cells. 
Since proteases do not cleave the e(Y-glutamyl)lysine crosslink 
formed by tTG [16] the amount of isodipeptide released into 
blood circulation following phagocytosis and degradation of 
apoptotic bodies may reflect the rate of apoptosis in tissues 
including lymph nodes and T cells [24,25]. As the involution 
of thymus was initiated the concentration of the isodipeptide 
Fig. 5. Apoptotic morphology of thymocytes after DXM or fas treatment. (A) DXM-treated animal with lymphocytes undergoing the classic 
('orderly') apoptotic changes. (Magnification X5200). Inset: two lymphocytes one with perinuclear space dilatation, the other with typical nu-
clear condensation (magnification X 13000). (B) Apoptosis induced by/as-stimulation is characterized by a more irregular fragmentation of 
cells and sieve-like cytoplasmic changes. (Magnification X5200). Inset: two lymphocytes with various degrees of nuclear condensation but 
marked enlargement of the endoplasmatic reticulum and/or lysosomes. (Magnification X 13000). 
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Table 1 
Changes in 
Treatment 
the plasma e(y-glutamyl)lysine isodipeptide level at various 
Isodipeptide level (nmol/ml) 
Time after treatment (h) 
0 6 
time points after the induction of 
12 
apoptosis by 
24 
various treatments 
48 
Control 
Dexamethasone 
Anti-CD3 antibody 
Irradiation 
Anti-fas antibody 
1.65 1.32 
1.34 
1.92 
3.05 
1.69 
1.71 
2.86 
2.42 
3.21 
2.01 
1.75 
4.33 
4.61 
5.73 
1.87 
1.68 
3.81 
4.42 
6.54 
1.92 
Data are values of one representative experiment and are the result of determination from pooled plasmas of three mice for each time point after 
various treatments. 
in plasma was increased in case of each treatment with the 
exception of anti-/oy antibody, where only a slight decrease 
was found at 12 h (Table 1). These findings suggest that tTG 
is not only induced but activated during apoptosis initiated by 
DXM, anti-CD3 treatment or irradiation. Though the time 
course of the decrease in thymic weight was very similar after 
these three treatments, the increase in the isodipeptide level 
was much more pronounced and earlier in irradiated animals 
than in the others. This observation may be explained by the 
selective action of DXM and anti-CD3 on lymphoid cells, 
while irradiation can induce apoptosis in other cell types as 
well (e.g. intestinal epithelial cells, bone marrow cells and 
others [26]). The slight but reproducible increase in isopeptide 
level found in anti-/oy-treated animals, on the other hand, 
may reflect the apoptosis of other fas bearing cells which 
constitutively express tTG [27]. In these cells tTG can be 
activated by increases in intracellular Ca2+ triggered by fas 
engagement [28]. 
3.4. Fas-induced cell death is characterized with a less 
organized morphology 
Thymus samples after various treatments were studied with 
TEM. A consistent feature at all magnifications used became 
obvious: animals treated with DXM (Fig. 5A), anti-CD3 anti-
body or irradiation (sections are not shown) displayed pro-
nounced apoptotic changes of the lymphocytes, usually dis-
playing the classical ultrastructural changes with relatively 
frequently started by the dilatation of the perinuclear space. 
Apoptosis that was induced by /os-receptor stimulation ap-
peared more dramatic with conspicuous fragmentation of 
the cells resulting in a much less orderly, sometimes even 
chaotic morphology. The cytoplasm of the lymphocytes in 
this series often became sieve-like due to marked dilatation 
of lysosomes and RER (Fig. 5B). 
4. Discussion 
According to our current understanding of the molecular 
mechanism of apoptosis a variety of signaling processes, ini-
tiated by either the appearance of apoptosis factors or the 
disappearance of survival factors, induce and/or activate a 
set of apoptotic effector elements. The latter are usually en-
zymes which catalyze irreversible biochemical reactions such 
as DNA degradation, proteolysis and cross-linking of proteins 
[29]. Little is known, however, about the transmittance of the 
death signals to these effector elements. One of the reasons for 
the lack of detailed information is the complexity of most of 
the effector enzyme systems. It is still not clarified which of 
the candidate endonucleases [30-32] degrade DNA. Several 
sets of proteases [2,3,5], including a family of interleukin-lp-
converting enzymes [13], have been linked to the death proc-
ess. Additionally, these endonucleases and proteases are ex-
pressed constitutively and are only activated via apoptosis 
signalling pathways. 
tTG may serve as a better candidate for studies designed to 
understand the link between the apoptosis signalling pathways 
and the apoptosis effector elements, since it is the only mem-
ber of the transglutaminase enzyme family which has been 
implicated to participate in the apoptotic process [15] and it 
is one of the very few genes which have been found to be 
induced during apoptosis resulting in a significant accumula-
tion of the enzyme protein in pre-apoptotic and apoptotic 
cells [15]. An additional advantage is the possibility of deter-
mining, with the help of measuring e(y-glutamyl)lysine isodi-
peptide concentration in blood plasma, whether the enzyme 
was active or not in the dying cells. The data presented here 
are the first to show that within the same cell type various 
signals leading to cell death regulate differentially the expres-
sion and activity of tTG. While stimulation of both a cell 
surface (TCR), a nuclear receptor (steroid receptor) or a nu-
clear transcription factor (p53) induced the expression and 
activation of tTG in thymocytes, stimulation of the fas recep-
tor did not. 
The /as-mediated cell death pathway has been reported to 
have many unusual characteristics. Unlike others, fas-induced 
cell death does not necessarily require macromolecular syn-
thesis, is not blocked by bcl-2 protein alone [33,34] (though 
the lack of bcl-2 inhibition is dependent on cell type [35,36]) 
and typical cytoplasmic changes of apoptosis can occur in the 
absence of the nucleus [37]. The fas signalling pathway in-
volves cysteine proteinase(s). Deletion of the gene or inhibi-
tion of the interleukin-lp-converting enzyme in mice renders 
thymocytes relatively resistant to/as-induced death [14,38] but 
not to other forms of apoptosis. The lack of the induction of 
tTG can be added now to the list of differences found between 
/as-dependent and other forms of apoptosis. 
The mechanism of the regulation of tTG expression during 
steroid receptor-, TCR- and />55-dependent apoptosis is not 
yet clear. It seems to occur at transcriptional level, since trans-
genic mice carrying the bacterial (3-galactosidase enzyme 
under the expressional control of tTG promoter express an 
increased level of the bacterial enzyme in the apoptotic thy-
mus (our yet unpublished observation). Additionally, in all 
cases studied so far the mechanism of tTG induction in apop-
totic cells has turned out to be transcriptional [15,39,40]. The 
regulation may involve the synthesis and/or activation of a so 
far unidentified transcriptional factor which results in a higher 
level of tTG mRNA and protein upon induction of apoptosis. 
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Alternatively, the regulatory regions of the tTG gene may 
contain a relatively large number of response elements (ster-
oid, retinoid, p53 and others) which can be utilized by the 
apoptotic stimuli. Further studies in our laboratory are in 
progress to differentiate between these alternatives. 
The time course of the appearance of tTG after apoptosis 
induction in thymic sections, as compared to that of the apop-
totic nuclei, shows that the induction of the enzyme is prior to 
the activation of the endonuclease. This may suggest that in-
duction of the tTG may play role in the initiation of the 
apoptotic program induced by signals depending on new 
mRNA sysnthesis. Indeed, it was shown that transfection of 
tTG into balb-c 3T3 fibroblasts induces a high rate of apop-
tosis [41], and in some forms of apoptosis blocking the induc-
tion and of tTG has lead to the inhibition of the apoptotic 
program [42]. Generally, transglutaminase-dependent forma-
tion of stable cross-links leads to protein polymerization and 
confers resistance to breakage and chemical attack [16]. In 
several apoptosis models the inhibition of the enzyme resulted 
in an increased leakage of intracellular macromolecules [15], 
suggesting a potential role of the enzyme in stabilizing cellular 
structures until phagocytosis of the apoptotic bodies takes 
place. Further studies will reveal how the presented morpho-
logic differences between the/as-mediated and tTG expressing 
forms of apoptosis are related to the protein crosslinking 
function of the enzyme. 
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